Spire Healthcare Group plc (LON:SPI - Get Free Report)'s share price passed above its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of GBX 193.70 ($2.63) and traded as high as GBX 213.50 ($2.90). Spire Healthcare Group shares last traded at GBX 209.50 ($2.84), with a volume of 587,052 shares changing hands.
Analyst Upgrades and Downgrades
Separately, Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Spire Healthcare Group from GBX 320 ($4.34) to GBX 300 ($4.07) and set a "buy" rating for the company in a research note on Thursday, March 6th.
Check Out Our Latest Analysis on SPI
Spire Healthcare Group Trading Down 0.5%
The firm has a 50-day moving average price of GBX 193.70 and a 200-day moving average price of GBX 207.85. The company has a debt-to-equity ratio of 62.25, a quick ratio of 0.74 and a current ratio of 0.70. The stock has a market cap of £837.27 million, a PE ratio of 29.67, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.
About Spire Healthcare Group
(
Get Free Report)
Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.
Further Reading
Before you consider Spire Healthcare Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Spire Healthcare Group wasn't on the list.
While Spire Healthcare Group currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
